STOCKHOLM: The Board of Directors of Moberg Pharma AB has resolved to carry out a fully guaranteed issue of new ordinary shares with preferential rights for existing shareholders of approximately SEK 121 million before transaction costs. The Rights Issue is conditional upon approval at an extraordinary general meeting. The net proceeds will be used for…